Certara (CERT) vs DarioHealth (DRIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Certara (CERT) has outperformed DarioHealth (DRIO) over the past year, losing 33.5% versus a loss of 66.8%. Over five years, CERT leads with a -77.2% price change compared with -98.3% for DRIO. Certara is the larger company by market cap ($1.32 billion vs $53.2 million), about 24.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CERT | DRIO |
|---|---|---|
| Share price | $8.64 | $5.43 |
| Market cap | $1.32B | $53.21M |
| 1-day change | -3.57% | -10.69% |
| YTD return | -1.93% | -52.28% |
| 1-year return | -33.54% | -66.83% |
| 5-year return | -77.17% | -98.32% |
| Forward P/E | 22.17 | — |
| EPS (TTM) | $-0.13 | $-2.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.11 | $16.50 |
| 52-week low | $4.45 | $5.43 |
| Distance from 52-week high | -34.10% | -67.09% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +0.81% | +150.46% |
| Average volume | 3.10M | 25.00K |
| Shares outstanding | 152.54M | 9.80M |
| Employees | 1,515 | 160 |
| Sector | Healthcare | Healthcare |
| Industry | Health Information Services | Health Information Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Certara is about 24.8 times larger than DarioHealth by market value ($1.32B vs $53.21M).
- CERT has outperformed DRIO by 33.3 percentage points over the past year.
About Certara
CERT stock →Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes.
Healthcare · Health Information Services · 1,515 employees
About DarioHealth
DRIO stock →DarioHealth Corp. operates as a digital health company in the United States and internationally.
Healthcare · Health Information Services · 160 employees
CERT vs DRIO FAQ
Which is bigger, Certara or DarioHealth?
Certara (CERT) is larger, with a market capitalization of $1.32B compared with $53.21M for DarioHealth (DRIO).
Which stock has performed better over the past year, CERT or DRIO?
CERT returned -33.54% over the past 12 months, compared with -66.83% for DRIO (price return, excluding dividends). Past performance does not predict future results.
Are Certara and DarioHealth in the same industry?
Yes. Both are classified in the Health Information Services industry within the Healthcare sector.